Torthaí cuardaigh - Lindsay Kilburn

  • 1 - 19 toradh as 19 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma

    Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma de réir Nadia Barahmani, Sarah C. Carpentieri, Xio-Nan Li, Tao Wang, Yumei Cao, Laura Howe, Lindsay Kilburn, Murali Chintagumpala, Ching C. Lau, M. Fatih Okcu

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid

    Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid de réir Amanda Saratsis, Sridevi Yadavilli, Suresh N. Magge, Brian R. Rood, Jennifer Pérez, D. Ashley Hill, Eugene Hwang, Lindsay Kilburn, Roger J. Packer, Javad Nazarian

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report

    Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report de réir Jack Su, Lindsay Kilburn, David B. Mansur, Mark Krailo, Allen Buxton, Adesina Adekunle, Amar Gajjar, Peter C. Adamson, Brenda J. Weigel, Elizabeth Fox, Susan M. Blaney, Maryam Fouladi

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Handheld Optical Coherence Tomography During Sedation in Young Children With Optic Pathway Gliomas

    Handheld Optical Coherence Tomography During Sedation in Young Children With Optic Pathway Gliomas de réir Robert A. Avery, Eugene Hwang, Hiroshi Ishikawa, Maria T. Acosta, Kelly A. Hutcheson, Domiciano Santos, Dina J. Zand, Lindsay Kilburn, Kenneth N. Rosenbaum, Brian R. Rood, Joel S. Schuman, Roger J. Packer

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)

    Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002) de réir Theodore Nicolaides, Kellie J. Nazemi, John R. Crawford, Lindsay Kilburn, Jane E. Minturn, Amar Gajjar, Karen Gauvain, Sarah Leary, Girish Dhall, Mariam Aboian, Giles Robinson, Janel Long‐Boyle, Hechuan Wang, Annette M. Molinaro, Sabine Mueller, Michael D. Prados

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

    Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047) de réir Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan Robison, Lindsay Kilburn, Anna Vinitsky, William D. Figg, Nada Jabado, Maryam Fouladi, Jason Fangusaro, Arzu Onar‐Thomas, Ira J. Dunkel, Katherine E Warren

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†

    A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report† de réir Jack M. Su, Patrick Thompson, Adekunle Adesina, Xiao‐Nan Li, Lindsay Kilburn, Arzu Onar‐Thomas, Mehmet Koçak, Brenda Chyla, Evelyn McKeegan, Katherine E. Warren, Stewart Goldman, Ian F. Pollack, Maryam Fouladi, Alice P. Chen, Vincent L. Giranda, James M. Boyett, Larry E. Kun, Susan M. Blaney

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy

    Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy de réir Eshini Panditharatna, Lindsay Kilburn, Mariam Aboian, Madhuri Kambhampati, Heather Gordish‐Dressman, Suresh N. Magge, Nalin Gupta, John S. Myseros, Eugene Hwang, Cassie Kline, John R. Crawford, Katherine E. Warren, Soonmee Cha, Winnie S. Liang, Michael E. Berens, Roger J. Packer, Adam Resnick, Michael D. Prados, Sabine Mueller, Javad Nazarian

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study

    A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study de réir Patricia Baxter, Jack M. Su, Arzu Onar‐Thomas, Catherine A. Billups, Xiao‐Nan Li, Tina Young Poussaint, Edward R. Smith, Patrick Thompson, Adekunle M. Adesina, Pete Ansell, Vincent L. Giranda, Arnold C. Paulino, Lindsay Kilburn, Ibrahim Quaddoumi, Alberto Broniscer, Susan M. Blaney, Ira J. Dunkel, Maryam Fouladi

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference

    Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference de réir Roger J. Packer, Antonio Iavarone, David Jones, Jaishri O. Blakeley, Éric Bouffet, Michael J. Fisher, Eugene Hwang, Cynthia Hawkins, Lindsay Kilburn, Tobey J. MacDonald, Stefan M. Pfister, Brian Rood, Fausto J. Rodríguez, Uri Tabori, Vijay Ramaswamy, Yuan Zhu, Jason Fangusaro, Stephen Albert Johnston, David H. Gutmann

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

    A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study de réir Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal I. Lindeman, Olivia Campagne, Anu Banerjee, Sridharan Gururangan, Lindsay Kilburn, Stewart Goldman, Ibrahim Qaddoumi, Patricia Baxter, Gilbert Vézina, Corey Bregman, Zoltán Patay, Jeremy Jones, Clinton F. Stewart, Michael J. Fisher, L. Austin Doyle, Malcolm A. Smith, Ira J. Dunkel, Maryam Fouladi

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RA... de réir Cornelis M. van Tilburg, Lindsay Kilburn, Sébastien Perreault, René Schmidt, Amedeo A. Azizi, Ofelia Cruz, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten–van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li‐Pen Tsao, Samuel C. Blackman, Peter Manley, Till Milde, Ruth Witt, David Jones, Darren Hargrave, Olaf Witt

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

    Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003 de réir Cassie Kline, Payal Jain, Lindsay Kilburn, Erin R. Bonner, Nalin Gupta, John R. Crawford, Anu Banerjee, Roger J. Packer, Javier Villanueva-Meyer, Tracy Luks, Yalan Zhang, Madhuri Kambhampati, Jie Zhang, Sridevi Yadavilli, Bo Zhang, Krutika S. Gaonkar, Jo Lynne Rokita, Adam Kraya, John G. Kuhn, Winnie S. Liang, Sara A. Byron, Michael E. Berens, Annette M. Molinaro, Michael D. Prados, Adam Resnick, Sebastian M. Waszak, Javad Nazarian, Sabine Mueller

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium

    A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium de réir Sabine Mueller, Payal Jain, Winnie S. Liang, Lindsay Kilburn, Cassie Kline, Nalin Gupta, Eshini Panditharatna, Suresh N. Magge, Bo Zhang, Yuankun Zhu, John R. Crawford, Anu Banerjee, Kellie J. Nazemi, Roger J. Packer, Claudia Petritsch, Nathalène Truffaux, Alison Roos, Sara Nasser, Joanna J. Phillips, David A. Solomon, Annette M. Molinaro, Angela J. Waanders, Sara A. Byron, Michael E. Berens, John G. Kuhn, Javad Nazarian, Michael D. Prados, Adam Resnick

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

    ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma de réir Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia, Dolly Aguilera, Joshua E. Allen, Tracy T. Batchelor, Nicholas Butowski, Clark C. Chen, Timothy F. Cloughesy, Andrew Cluster, John de Groot, Karan Dixit, Jerome Graber, Aya Haggiagi, Rebecca A. Harrison, Albert Kheradpour, Lindsay Kilburn, Sylvia C. Kurz, Guangrong Lu, Tobey J. MacDonald, Minesh P. Mehta, Allen S. Melemed, Phioanh L. Nghiemphu, Samuel Ramage, Nicole Shonka, Ashley Sumrall, Rohinton S. Tarapore, Lynne P. Taylor, Yoshie Umemura, Patrick Y. Wen

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Pediatric low-grade gliomas: implications of the biologic era

    Pediatric low-grade gliomas: implications of the biologic era de réir Roger J. Packer, Stefan M. Pfister, Éric Bouffet, Robert A. Avery, Pratiti Bandopadhayay, Miriam Bornhorst, Daniel C. Bowers, David W. Ellison, Jason Fangusaro, Nicholas K. Foreman, Maryam Fouladi, Amar Gajjar, Daphne A. Haas‐Kogan, Cynthia Hawkins, Cheng‐Ying Ho, Eugene I. Hwang, Nada Jabado, Lindsay Kilburn, Álvaro Lassaletta, Keith L. Ligon, Maura Massimino, Schouten-van Meeteren, Sabine Mueller, Theo Nicolaides, Giorgio Perilongo, Uri Tabori, Gilbert Vézina, Katherine E. Warren, Olaf Witt, Yuan Zhu, David Jones, Mark W. Kieran

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

    Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial de réir Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal I. Lindeman, Anuradha Banerjee, Roger J. Packer, Lindsay Kilburn, Stewart Goldman, Ian F. Pollack, Ibrahim Qaddoumi, Regina I. Jakacki, Paul G. Fisher, Girish Dhall, Patricia Baxter, Susan G. Kreissman, Clinton F. Stewart, David Jones, Stefan M. Pfister, Gilbert Vézina, Jessica Stern, Ashok Panigrahy, Zoltán Patay, Benita Tamrazi, Jeremy Jones, Sofia Haque, David S. Enterline, Soonmee Cha, Michael J. Fisher, L. Austin Doyle, Malcolm A. Smith, Ira J. Dunkel, Maryam Fouladi

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

    The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial de réir Lindsay Kilburn, Dong-Anh Khuong-Quang, Jordan R. Hansford, Daniel Landi, Jasper van der Lugt, Sarah Leary, Pablo Hernáiz Driever, Simon Bailey, Sébastien Perreault, Geoffrey McCowage, Angela J. Waanders, David S. Ziegler, Olaf Witt, Patricia Baxter, Hyoung Jin Kang, Tim Hassall, Jung Woo Han, Darren Hargrave, Andrea Franson, Michal Oren, Helen Toledano, Valérie Larouche, Cassie Kline, Mohamed S Abdelbaki, Nada Jabado, Nicholas G. Gottardo, Nicolas U. Gerber, Nicholas Whipple, Devorah Segal, Susan Chi, Liat Oren, Enrica Tan, Sabine Mueller, Izzy Cornelio, Lisa McLeod, Xin Zhao, Ashley A. Walter, Daniel Da Costa, Peter Manley, Samuel C. Blackman, Roger J. Packer, Karsten Nysom

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

    PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma de réir Ryan J. Duchatel, Evangeline R. Jackson, Sarah Parackal, Dylan J. Kiltschewskij, Izac J. Findlay, Abdul Mannan, Dilana E. Staudt, Bryce C. Thomas, Zacary P. Germon, Sandra Laternser, Padraic S. Kearney, M. Fairuz B. Jamaluddin, Alicia M. Douglas, Tyrone S. Beitaki, Holly P. McEwen, Mika L. Persson, Emily Hocke, Vaibhav Jain, Michael Aksu, Elizabeth E. Manning, Heather C. Murray, Nicole M. Verrills, Claire Sun, Paul Daniel, Ricardo E. Vilain, David A. Skerrett‐Byrne, Brett Nixon, Susan Hua, Charles E. de Bock, Yolanda Colino‐Sanguino, Fátima Valdés‐Mora, Maria Tsoli, David S. Ziegler, Murray J. Cairns, Eric H. Raabe, Nicholas A. Vitanza, Esther Hulleman, Timothy N. Phoenix, Carl Koschmann, Frank Alvaro, Christopher V. Dayas, Christopher L. Tinkle, Helen Wheeler, James R. Whittle, David D. Eisenstat, Ron Firestein, Sabine Mueller, Santosh Valvi, Jordan R. Hansford, David M. Ashley, Simon G. Gregory, Lindsay Kilburn, Javad Nazarian, Jason E. Cain, Matthew D. Dun

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: